Karen J. Wilson, SVP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 18,166 shares at $152.24 ($2.8M) on 2017-04-10, disclosed to the SEC on 2017-04-11.
Open-market sale of $2.8M JAZZ by SVP, Finance & PAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.24 | 4,750 | $723K | 26.1% |
| 2 | $152.24 | 6,708 | $1.0M | 36.9% |
| 3 | $152.24 | 6,708 | $1.0M | 36.9% |
| Total | $152.24 avg | 18,166 | $2.8M | 100% |
| Filing → |
| JAZZ | SELL | 2018-05-15 | $620K | — | Filing → |
| JAZZ | SELL | 2018-04-12 | $604K | — | Filing → |
| JAZZ | SELL | 2017-04-27 | $204K | — | Filing → |